{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T01:20:17Z","timestamp":1789953617256,"version":"4.0.1"},"reference-count":15,"publisher":"Informa UK Limited","issue":"10","funder":[{"DOI":"10.13039\/100006436","name":"Celgene","doi-asserted-by":"publisher","award":["N.A."],"award-info":[{"award-number":["N.A."]}],"id":[{"id":"10.13039\/100006436","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Clinical Pharmacology"],"published-print":{"date-parts":[[2017,10,3]]},"DOI":"10.1080\/17512433.2017.1365598","type":"journal-article","created":{"date-parts":[[2017,8,10]],"date-time":"2017-08-10T05:26:28Z","timestamp":1502342788000},"page":"1153-1160","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":42,"title":["Comparison of treatment patterns and economic outcomes among metastatic pancreatic cancer patients initiated on <i>nab<\/i>-paclitaxel plus gemcitabine versus FOLFIRINOX"],"prefix":"10.1080","volume":"10","author":[{"given":"Ali","family":"McBride","sequence":"first","affiliation":[{"name":"The University of Arizona Cancer Center, Phoenix, AZ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Machaon","family":"Bonafede","sequence":"additional","affiliation":[{"name":"Truven Health Analytics, an IBM company, Ann Arbor, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Cai","sequence":"additional","affiliation":[{"name":"Truven Health Analytics, an IBM company, Ann Arbor, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Princic","sequence":"additional","affiliation":[{"name":"Truven Health Analytics, an IBM company, Ann Arbor, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oth","family":"Tran","sequence":"additional","affiliation":[{"name":"Truven Health Analytics, an IBM company, Ann Arbor, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey","family":"Pelletier","sequence":"additional","affiliation":[{"name":"Celgene Corporation, Summit, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Parisi","sequence":"additional","affiliation":[{"name":"Celgene Corporation, Summit, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Patel","sequence":"additional","affiliation":[{"name":"Celgene Corporation, Summit, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2017,8,21]]},"reference":[{"key":"CIT0002","unstructured":"Howlader N, Noone A, Krapcho M, et al. SEER cancer statistics review. Bethesda (MD): National Cancer Institute; 2015. p. 1975\u20132012."},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.67.1412"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1011923"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1304369"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2016.1269015"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-016-0762-8"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2017.1302330"},{"key":"CIT0010","first-page":"187","volume":"7","author":"Al-Hajeili M","year":"2014","journal-title":"Onco Targets Ther"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2015.03.008"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(92)90133-8"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.27490"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2014.03.768"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2016.03.1555"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2016.11.002"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2015.65"}],"container-title":["Expert Review of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17512433.2017.1365598","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,9,28]],"date-time":"2017-09-28T10:49:33Z","timestamp":1506595773000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17512433.2017.1365598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,21]]},"references-count":15,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2017,7,17]]},"published-print":{"date-parts":[[2017,10,3]]}},"alternative-id":["10.1080\/17512433.2017.1365598"],"URL":"https:\/\/doi.org\/10.1080\/17512433.2017.1365598","relation":{},"ISSN":["1751-2433","1751-2441"],"issn-type":[{"value":"1751-2433","type":"print"},{"value":"1751-2441","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,21]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierj20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierj20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"}]}}